Effectiveness and safety of monthly versus quarterly fremanezumab for migraine prevention: An Italian, multicenter, real‐life study
Laura Zanandrea(Vita-Salute San Raffaele University), Massimo Filippi(Vita-Salute San Raffaele University), Sabina Cevoli(Istituto delle Scienze Neurologiche di Bologna), Federica Genovese(University of Turin), Simone Guerrieri(Vita-Salute San Raffaele University), Roberta Messina(Vita-Salute San Raffaele University), Ilaria Cetta(Vita-Salute San Raffaele University), Valentina Favoni(Istituto delle Scienze Neurologiche di Bologna), Claudia Altamura(Università Campus Bio-Medico), Fabrizio Vernieri(Università Campus Bio-Medico), Bruno Colombo(Vita-Salute San Raffaele University)
Cited by 5
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Multiple sclerosis
|Nature Reviews Disease Primers|2018|1.4k